Adaptive BiotechnologiesADPT 
$4.630.87%24h
0.87%24h
Global rank9793
Market cap$670.30M
Change 7d8.43%
YTD Performance-6.28%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Adaptive Biotechnologies (ADPT)
As of November 2024, Adaptive Biotechnologies has a market cap of $670.30M. This makes Adaptive Biotechnologies the world's 9793th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Adaptive Biotechnologies from 2019 to 2024
-
Value:-
Market cap history of Adaptive Biotechnologies from 2019 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $567.51M | -20.00% |
| 2023 | $709.39M | -35.86% |
| 2022 | $1.11B | -72.77% |
| 2021 | $4.06B | -52.55% |
| 2020 | $8.56B | 97.63% |
| 2019 | $4.33B | - |
ADPT Market Cap Today is $670.30M 0.87% - 17 Nov 2024
View largest stocks by market cap 
